XXI SEMINANOSOMA

Anais do XXI Seminário Internacional Nanotecnologias, Sociedade e Meio Ambiente desafios jurídicos éticos e sociais para a “grande transição sustentável” (XXI SEMINANOSOMA) 136 Creutzenberg, O. Nanoparticles and their regulation. Springer ebooks, p. 1–17, 2021. Crist, R. M. et al. Advancements in nanoparticle characterization. Methods in molecular biology, p. 3–17, 2024. Davis, K. E. The limits of evidence-based regulation: the case of an- ti-bribery law. SSRN electronic journal, 2019. Dekkers, S. et al. Towards a nanospecific approach for risk assessment. Regulatory toxicology and pharmacology, v. 80, p. 46–59, 2016. Devasahayam, S. Nanotechnology and nanomedicine in market. Characterization and biology of nanomaterials for drug de- livery, p. 477–522, 2019. Facchini, F. et al. Industry 4.0 enabling technologies application in healthcare areas – a systematic review. Proceedings international conference on industrial engineering and operations management, 2020. Forest, V. Experimental and computational nanotoxicology–comple- mentary approaches for nanomaterial hazard assessment. Nanomaterials, v. 12, n. 8, p. 1346, 2022. Furxhi, I. et al. Status, implications and challenges of european safe and sustainable by design paradigms applicable to nanoma- terials and advanced materials. RSC Sustainability, v. 1, n. 2, p. 234–250, 2023. Gambardella, C.; Pinsino, A. Nanomaterial ecotoxicology in the terrestrial and aquatic environment: a systematic review. Toxics, v. 10, n. 7, p. 393, 2022. Geological Survey, U. Mineral commodity summaries 2024. [s.l: s.n.]. Gottardo, S. et al. NANoREG framework for the safety assessment of nanomaterials. JRC Publications Repository, 2017. Gruber, S.; Nickel, A. Toxic or not toxic? The specifications of the stan- dard iso 10993-5 are not explicit enough to yield comparable results in the cytotoxicity assessment of an identical medical device. Frontiers in medical technology, v. 5, 2023. Halamoda-Kenzaoui, B. et al. Future perspectives for advancing reg- ulatory science of nanotechnology-enabled health products. Drug delivery and translational research, v. 12, n. 9, p. 2145–2156, 2022. Hansson, S. O. How extreme is the precautionary principle? Nanoethics, v. 14, n. 3, p. 245–257, 2020.

RkJQdWJsaXNoZXIy MjEzNzYz